Doma Biopharmaceutical has raised $134M in total funding. Latest round: Series A. Backed by Biocytogen, China Life Private Equity Investment, PICC Capital.
Doma Biopharmaceutical has raised $134M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Doma Biopharmaceutical runs through 2022; nothing later has been disclosed. Investors on record include Biocytogen, China Life Private Equity Investment, PICC Capital, Suzhou Industrial Park Hefeng Capital, Taiping Healthcare Fund, CMB International and 1 others. 7 distinct backers are named across the disclosed rounds.
Doma Biopharmaceutical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026